| click here for details Verkazia (U.S.N.L.M.) | |
|---|---|
| Dosing | Shake. Instill one drop 4 times daily (morning, noon, afternoon, and evening) |
| Chem Specs | 0.1% cyclosporine emulsion |
| Quantities | 120 Single-Dose Vials 0.3 mL each. (24 pouches of 5ea) |
| Cost | |
| Class | calcineurin inhibitor immunosuppressant |
| Action | Blocks release of pro-inflammatory cytokines. |
| Usage | Indicated for the treatment of vernal keratoconjunctivitis (VKC) in children and adults. |
| Warnings | Do not touch tip to eye. 18% report eye pain or discomfort on instillation. |
| Contraindications | None |
| Pediatric use | Safety and effectiveness has been established in patients from 4 through 18 |
| Pregnancy | There are no adequate and well-controlled studies of Verkazia administration in pregnant women to inform a drug-associated risk. Oral administration of cyclosporine to pregnant rats or rabbits did not produce teratogenicity at clinically relevant doses |